HK Stock MarketDetailed Quotes

JUNSHI BIO (01877)

Watchlist
  • 24.800
  • -0.500-1.98%
Trading May 7 10:24 CST
25.46BMarket Cap-35.89P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

JUNSHI BIO (01877) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
Drug sales2.3B92.11%
许可收入160.84M6.44%
Service income33.82M1.35%
Other2.36M0.09%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Drug sales2.3B92.11%
许可收入160.84M6.44%
Service income33.82M1.35%
Other2.36M0.09%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
China1.07B91.95%
Other53.72M4.60%
United States of America40.31M3.45%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.72%
Sample Name
Sample Code
 +3.83%
Sample Name
Sample Code
 +1.09%
4
SHANGHAI PECHEM
00338
+0.78%
5
SINOPEC CORP
00386
0.00%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +65.82%
Sample Name
Sample Code
 +57.80%
Sample Name
Sample Code
 +43.93%
4
Loongson Technology Corporation
688047
+43.93%
5
Digital China Group
000034
+25.98%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -